1
Phase 2 study reports significantly accelerated debridement and wound repair in venous leg ulcers
SolasCure has completed its second phase 2 clinical trial of Aurase Wound Gel, reporting results that indicate substantially faster healing in patients with chronic venous leg ulcers.
The company said the CLEANVLU2 study provides clinical validation that the investigational treatment can deliver continuous enzymatic debridement while also activating wound healing.
Aurase Wound Gel combines a proprietary hydrogel with the active pharmaceutical ingredient tarumase. CLEANVLU2 followed the…